Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In the STEP 1 trial, semaglutide 2.4mg produced an average body weight reduction of approximately 14.9% at 68 weeks in people with obesity
keep container tightly closed Intended Use : For laboratory research use only
Disclaimer : Treatment must be medically necessary and prescribed by a licensed provider
This dual mechanism explains why the compound produces such pronounced effects on adipose tissue lipid content without affecting lean tissue or overall energy intake in research models
Key Features and Benefits Preservative Addition: Contains bacteriostatic agents to inhibit bacterial growth, enhancing its shelf life
By activating GLP-1 and GIP receptors, it enhances insulin secretion (when glucose is present) and suppresses appetite, similar to existing incretin therapies [7] [8]
US$ 28.41
US$ 27.04
US$ 26.15
US$ 23.23
US$ 21.45
US$ 23.50
